<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR143">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Martins</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Araujo</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Gomes</surname>
    <given-names>MJ</given-names>
   </name>
   <name>
    <surname>Fernandes</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Nunes</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Santos</surname>
    <given-names>HA</given-names>
   </name>
   <name>
    <surname>Borges</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Sarmento</surname>
    <given-names>B</given-names>
   </name>
  </person-group>
  <article-title>Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy</article-title>
  <source>Eur J Pharm Biopharm</source>
  <year>2019</year>
  <volume>138</volume>
  <fpage>111</fpage>
  <lpage>124</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejpb.2018.01.014</pub-id>
  <?supplied-pmid 29397261?>
  <pub-id pub-id-type="pmid">29397261</pub-id>
 </element-citation>
</ref>
